Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1176.8000 -3.30 (-0.28%)
NSE Jan 16, 2026 14:57 PM
Volume: 701.8K
 

logo
Aurobindo Pharma Ltd.
10 Feb 2025
1176.80
-0.28%
buy
by Axis Direct
Target: 1500 | Upside : 27.5%
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a target price of Rs 1,500/share
 
Aurobindo Pharma Ltd. is trading above its 200 day SMA of 1145.0
More from Aurobindo Pharma Ltd.
Recommended
Market trades higher, Leela Palaces Hotels & Resorts' Q3FY26 net profit surges 162% YoY
Trendlyne Marketwatch | 16 Jan 2026, 02:46PM
Nifty 50 outlook: Hopes rise for 2026 after a volatile year
The Baseline | 15 Jan 2026, 01:13PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020, 03:06PM